Robyn Karnauskas Stock Analyst Profile - Truist Securities Research Coverage - Stocknear

Robyn Karnauskas

Stock Analyst at Truist Securities

(3.7)
# 2427
Out of 5,506 analysts
218
Total ratings
Success rate
Average return

44 Stocks

Name Action PT Current % Upside Ratings Updated
TRML Tourmaline Bio
Downgrades: Hold
63 48
47.9 0.21% 3 Sep 10, 2025
ABCL AbCellera Biologics
Maintains: Buy
28 10
5.9 69.49% 2 May 16, 2025
AMGN Amgen
Maintains: Hold
333 298
297.89 0.04% 12 Jan 8, 2025
BMY Bristol-Myers Squibb
Maintains: Strong Buy
62 65
45.44 43.05% 2 Jan 8, 2025
MRK Merck & Co
Downgrades: Hold
130 110
89.17 23.36% 11 Jan 8, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
1033 1029
840.01 22.5% 5 Oct 31, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
82 83
112.69 -26.35% 15 Aug 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Strong Buy
195 210
233.87 -10.21% 8 Jul 26, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 3 Jun 11, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
340 340
159.88 112.66% 17 May 16, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
26 26
1.65 1475.76% 2 May 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
8 7
1.64 326.83% 13 May 13, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
1135 1135
600 89.17% 16 Apr 3, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
10
1.63 513.5% 2 Mar 26, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
9 9
3.38 166.27% 4 Mar 26, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
23
16.17 42.24% 5 Mar 25, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
48
16.9 184.02% 5 Mar 25, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
50
13.36 274.25% 8 Mar 25, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
456 508
403.12 26.02% 12 Jan 31, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
42 36
27.36 31.58% 5 Dec 14, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
29
n/a n/a 1 Oct 10, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
25
65.37 -61.76% 1 Oct 6, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 6 Oct 5, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
140
55.43 152.57% 5 Sep 25, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
30000
n/a n/a 2 Sep 6, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Hold
7
1.21 478.51% 3 Aug 16, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
65 55
54.92 0.15% 1 May 11, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 4 Dec 6, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
500 320
18.1 1667.96% 2 Aug 23, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
10 15
15.06 -0.4% 5 Aug 9, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
12 4
n/a n/a 2 Mar 31, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
65 10
n/a n/a 5 Nov 8, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
32
n/a n/a 4 Aug 6, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
580 120
n/a n/a 1 Mar 2, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
25
n/a n/a 1 Nov 11, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
85
1 8400% 1 Oct 8, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
180 165
n/a n/a 5 May 23, 2019
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
100 77
n/a n/a 6 Dec 17, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
60 44
n/a n/a 3 Aug 20, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
44 63
n/a n/a 3 Mar 1, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
n/a
n/a n/a 3 Feb 16, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Jan 18, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
62 87
n/a n/a 1 Mar 2, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Neutral
6 8
n/a n/a 1 Mar 3, 2016